Intraductal carcinoma in situ of the left breast is a non-invasive breast cancer characterized by the proliferation of malignant cells within the ducts of the breast tissue. This condition is clinically significant as it can progress to invasive breast cancer if left untreated. Accurate coding with ICD-10 Code D05.12 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code D05.12 specifically denotes intraductal carcinoma in situ of the left breast, indicating the presence of abnormal cells confined to the ducts without invasion into surrounding breast tissue. This code should be used in clinical documentation and billing when diagnosing patients with this condition, facilitating accurate treatment planning and reimbursement processes.
Intraductal carcinoma in situ of the left breast arises from the epithelial cells lining the milk ducts and is considered a precursor to invasive breast cancer. It is crucial to identify and treat this condition promptly to prevent progression. Regular screening and awareness of risk factors are essential for early detection.
ICD-10 Code D05.12 is utilized in SOAP notes to document the diagnosis of intraductal carcinoma in situ of the left breast. It plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D05.12 connects subjective reports from patients and objective clinical findings to a formal diagnosis of intraductal carcinoma in situ of the left breast. This code is vital for maintaining continuity of care, supporting accurate billing, and adhering to EHR documentation standards.
Intraductal carcinoma in situ of the left breast requires timely intervention to prevent progression to invasive cancer. Treatment options may include surgical excision and, in some cases, radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.12 is critical in medical billing, particularly in hospital and outpatient settings, ensuring accurate claims for treatment of intraductal carcinoma in situ of the left breast.
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, partial (segmental resection) |
| 19281 | Biopsy of breast, needle |
| 77067 | Breast imaging, diagnostic mammography |
| 19302 | Mastectomy, total (simple) |
Common Questions About Using ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast
What are the treatment options for intraductal carcinoma in situ?
Treatment typically includes surgical excision, and in some cases, radiation therapy may be recommended to reduce the risk of recurrence. Regular follow-up is essential for monitoring.
How is intraductal carcinoma in situ diagnosed?
Diagnosis is usually made through mammography, which may reveal calcifications, followed by a biopsy to confirm the presence of abnormal cells.
Is intraductal carcinoma in situ considered cancer?
Yes, intraductal carcinoma in situ is classified as a non-invasive breast cancer, meaning it has not spread beyond the ducts into surrounding tissue.
What is the prognosis for intraductal carcinoma in situ?
The prognosis is generally favorable with appropriate treatment, as it is non-invasive. However, it requires monitoring due to the potential risk of progression to invasive cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes